Further, a recent study confirmed that FAK loss in ECs prevents pancreatic tumor metastasis in the presence of the chemotherapeutic drug gemcitabine, without affecting tumor size (Roy-Luzarraga et al., 2022). The gene discussed is PTK2; the disease is neoplasm.